Primary isoniazid resistance in Mycobacterium bovis disease: a prospect of concern

Am J Respir Crit Care Med. 2012 Jul 1;186(1):110-1. doi: 10.1164/ajrccm.186.1.110.
No abstract available

Publication types

  • Letter

MeSH terms

  • Abattoirs
  • Adult
  • Agriculture
  • Antitubercular Agents / pharmacology*
  • Antitubercular Agents / therapeutic use
  • Drug Resistance, Bacterial
  • Female
  • Humans
  • Incidence
  • Ireland / epidemiology
  • Isoniazid / pharmacology*
  • Isoniazid / therapeutic use
  • Male
  • Middle Aged
  • Mycobacterium bovis* / drug effects
  • Rifampin / therapeutic use
  • Tuberculosis / drug therapy*
  • Tuberculosis / epidemiology
  • Tuberculosis / microbiology*
  • Tuberculosis, Lymph Node / drug therapy
  • Tuberculosis, Lymph Node / epidemiology
  • Tuberculosis, Lymph Node / microbiology
  • Tuberculosis, Osteoarticular / drug therapy
  • Tuberculosis, Osteoarticular / epidemiology
  • Tuberculosis, Osteoarticular / microbiology
  • Tuberculosis, Pulmonary / drug therapy
  • Tuberculosis, Pulmonary / epidemiology
  • Tuberculosis, Pulmonary / microbiology

Substances

  • Antitubercular Agents
  • Isoniazid
  • Rifampin